Received Apr 9, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| DTAPIPV | DTAP + IPV (KINRIX) | GLAXOSMITHKLINE BIOLOGICALS | UNK | 7745R | — |
Kinrix administration instead of Infanrix; Kinrix under recommended age administration; This non-serious case was reported by a nurse via call center representative and described the occurrence of wrong vaccine administered in a 4-month-old male patient who received DTPa-IPV (Kinrix) (batch number 7745R, expiry date 22-AUG-2025) for prophylaxis. Co-suspect products included DTPa (Infanrix) for prophylaxis. On 24-FEB-2025, the patient received Kinrix. On an unknown date, the patient received Infanrix. On 24-FEB-2025, immediately after receiving Kinrix and not applicable after receiving Infanrix, the patient experienced wrong vaccine administered (Verbatim: Kinrix administration instead of Infanrix) and inappropriate age at vaccine administration (Verbatim: Kinrix under recommended age administration). The outcome of the wrong vaccine administered and inappropriate age at vaccine administration were not applicable. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt Date:28-MAR-2025 Registered Nurse wanted to know how to proceed with a patient that received Kinrix instead of Infanrix and if there was any possible harm for him in this situation, which led to wrong vaccine administered and inappropriate age at vaccine administration. Information her inquiries and also for Kinrix under recommended age administration was given. The reporter consented to follow up. The Vaccine Administration Facility is the same as Primary Reporter.